Suchergebnisse - "Rojas, Jhon"

PubPharm (41)

1

PrEP program experience in a hospital HIV unit. Description of baseline user profile and identification of opportunities for improvement

enthalten in: Enfermedades infecciosas y microbiologia clinica (English ed.) | 2023

von Laguno, M. | Ugarte, A. | Martinez-Rebollar, M. | +15

CommentOn: PLoS One. 2021 Feb 8;16(2):e0246129. - PMID 33556085

2

Simplification from tenofovir disoproxil fumarate plus lamivudine or emtricitabine plus ritonavir-boosted protease inhibitor to ritonavir-boosted atazanavir plus lamivudine in virologically suppressed HIV-infected adults with osteopenia : a pilot study

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Blanco, J. | Rojas, J. | de Lazzari, E. | +10

3

Prevention and Treatment of SARS-CoV2 Infection in People Living with HIV : The Need for Specific Data

enthalten in: Infectious diseases and therapy | 2022

von Díaz, N. | de Miguel, R. | Agüero, F. | +44

4

Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection

enthalten in: Trials | 2021

von Masiá, M. | Padilla, S. | Estañ, G. | +80

ErratumIn: Trials. 2023 Sep 27;24(1):614. - PMID 37759269

5

Gustatory and olfactory dysfunctions in hospitalised patients with COVID-19 pneumonia : a prospective study

enthalten in: BMJ open | 2021

von Inciarte, A. | Cardozo, C. | Chumbita, M. | +30

6

Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM) : a randomised non-inferiority trial

enthalten in: The lancet. HIV | 2021

von Rojas, J. | de Lazzari, E. | Negredo, E. | +14

CommentIn: Lancet HIV. 2021 Aug;8(8):e454-e455. - PMID 34358493

7

No Changes in Human Immunodeficiency Virus (HIV) Suppression and Inflammatory Markers in Cerebrospinal Fluid in Patients Randomly Switched to Dolutegravir Plus Lamivudine (Spanish HIV/AIDS Research Network, PreEC/RIS 62)

enthalten in: The Journal of infectious diseases | 2021

von Tiraboschi, J. | Rojas, J. | Zetterberg, H. | +10

8

PrEP program experience in a hospital HIV unit. Description of baseline user profile and identification of opportunities for improvement

enthalten in: Enfermedades infecciosas y microbiologia clinica (English ed.) | 2021

von Laguno, M. | Ugarte, A. | Martinez-Rebollar, M. | +15

9

Overview of SARS-CoV-2 infection in adults living with HIV

enthalten in: The lancet. HIV | 2021

von Ambrosioni, J. | Blanco, J. | Reyes-Urueña, J. | +48

10

Tocilizumab is associated with reduced risk of ICU admission and mortality in patients with SARS-CoV-2 infection

enthalten in: bioRxiv.org | 2021

von Moreno-García, E. | Rico, V. | Albiach, L. | +36

1
2
3
4
5
Nächster »
[5]